SCHEMBL1769434

SCHEMBL1769434

CC(C)(C)OC(=O)N1CCN(c2ccc3oc(C(N)=O)cc3c2)CC1

nearest known ligand 0.65

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
MAPT P10636 1/20 0.50
GPR119 Q8TDV5 1/20 0.50
HTR1A P08908 2/20 0.49
SLC6A2 P23975 2/20 0.49
SLC6A4 P31645 2/20 0.49
SLC6A3 Q01959 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12663220 0.91 ALDH1A1 (0.50) ALDH1A1LMNAMAPTGPR119
SCHEMBL1888484 0.91 ALDH1A1 (0.50) ALDH1A1LMNAMAPT
SCHEMBL29881025 0.91 ALDH1A1 (0.50) ALDH1A1LMNAMAPT
SCHEMBL13651528 0.89
SCHEMBL1886952 0.86
SCHEMBL29881798 0.86
SCHEMBL12527408 0.84 ALDH1A1 (0.48) ALDH1A1LMNAMAPTGPR119
SCHEMBL27983379 0.83 HTR1A (0.54) HTR1ASLC6A2SLC6A4SLC6A3
SCHEMBL1769397 0.82 ALDH1A1 (0.48) ALDH1A1LMNAMAPTGPR119
SCHEMBL17251233 0.82 SLC6A2 (0.53) HTR1ASLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121649-B1 Method for the production of benzofuran-2-carboxamides MERCK PATENT GMBH (DE) 2013-02-27 EP claimed
CN-101573347-B Process for preparing benzofuran-2-carboxamides MERCK PATENT GMBH 2012-10-10 CN claimed
US-20100036139-A1 PROCESS FOR THE PREPARATION OF BENZOFURAN-2-CARBOXAMIDES MERCK PATENT GMBH (DE) 2010-02-11 US claimed
EP-2121649-A1 METHOD FOR THE PRODUCTION OF BENZOFURAN-2-CARBOXAMIDES Merck Patent GmbH (DE) 2009-11-25 EP claimed
CN-101573347-A Process for preparing benzofuran-2-carboxamides MERCK PATENT GMBH (DE) 2009-11-04 CN claimed
WO-2008080456-A1 METHOD FOR THE PRODUCTION OF BENZOFURAN-2-CARBOXAMIDES MERCK PATENT GMBH (DE) 2008-07-10 WO claimed
CN-1181067-C Benzofurans Ĭ��ר���ɷ����޹�˾ 2004-12-22 CN claimed
EP-0738722-B1 5-Amino-benzofuran-2-carboxylic acid derivatives MERCK PATENT GMBH (DE) 2003-06-25 EP claimed
CN-1140171-A Benzofurans MERCK PATENT GMBH (DE) 1997-01-15 CN claimed
EP-0738722-A1 5-Amino-benzofuran-2-carboxylic acid derivatives MERCK PATENT GmbH (DE) 1996-10-23 EP claimed
CN-110092778-B Method for preparing vilazodone intermediate and vilazodone medicine by using cheap metal copper 浙江工业大学 2021-02-09 CN disclosed
US-20180002305-A1 PROCESS FOR PREPARING BENZOFURAN-2-CARBOXAMIDE DERIVATIVES SYMED LABS LIMITED (IN) 2018-01-04 US disclosed
US-9796695-B2 Process for preparing benzofuran-2-carboxamide derivatives SYMED LABS LIMITED (IN) 2017-10-24 US disclosed
US-20170267655-A1 PROCESS FOR PREPARING BENZOFURAN-2-CARBOXAMIDE DERIVATIVES SYMED LABS LIMITED (IN) 2017-09-21 US disclosed
US-9682946-B2 Process for preparing benzofuran-2-carboxamide derivatives SYMED LABS LIMITED (IN) 2017-06-20 US disclosed
WO-2001040219-A2 METHOD FOR PRODUCING 5-(1-PIPERAZINYL)-BENZOFURAN-2-CARBOXAMIDE BY TRANSITION METAL-CATALYZED AMINATION MERCK PATENT GMBH (DE) 2001-06-07 WO disclosed
US-5977112-A Process of making substituted benzofurans MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1999-11-02 US disclosed
US-5723614-A Benzofurans MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1998-03-03 US disclosed
CN-1140171-A Benzofurans MERCK PATENT GMBH (DE) 1997-01-15 CN disclosed
EP-0738722-A1 5-Amino-benzofuran-2-carboxylic acid derivatives MERCK PATENT GmbH (DE) 1996-10-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180002305-A1 PROCESS FOR PREPARING BENZOFURAN-2-CARBOXAMIDE DERIVATIVES HTR3C, VIL1, HTR4 ALDH1A1 329/4885LMNA 1710/4885MAPT 1828/4885
US-20170267655-A1 PROCESS FOR PREPARING BENZOFURAN-2-CARBOXAMIDE DERIVATIVES HTR3C, VIL1, HTR4 ALDH1A1 329/4885LMNA 1710/4885MAPT 1828/4885
US-20100036139-A1 PROCESS FOR THE PREPARATION OF BENZOFURAN-2-CARBOXAMIDES CCNT1, CCNT2, CBR1 ALDH1A1 396/4885LMNA 2166/4885MAPT 2936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.